Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2021

Jan 28, 2022

SELL
$198.88 - $227.6 $7,955 - $9,104
-40 Closed
0 $0
Q1 2021

Apr 27, 2021

SELL
$221.91 - $258.6 $4,216 - $4,913
-19 Reduced 32.2%
40 $10,000
Q2 2020

Aug 04, 2020

BUY
$197.81 - $242.74 $11,670 - $14,321
59 New
59 $14,000
Q3 2018

Nov 05, 2018

SELL
$185.29 - $208.89 $3,705 - $4,177
-20 Closed
0 $0
Q1 2018

May 15, 2018

SELL
$169.43 - $198.0 $1,863 - $2,178
-11 Reduced 35.48%
20 $3,000
Q3 2017

Feb 05, 2019

BUY
$167.29 - $191.0 $5,185 - $5,921
31
31 $6,000

Others Institutions Holding AMGN

About AMGEN INC


  • Ticker AMGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 534,931,008
  • Market Cap $169B
  • Description
  • Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...
More about AMGN
Track This Portfolio

Track Rpg Investment Advisory, LLC Portfolio

Follow Rpg Investment Advisory, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Rpg Investment Advisory, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Rpg Investment Advisory, LLC with notifications on news.